Marizanne Kapp and Anaya Bangar
She also revealed that her most recent blood test in July recorded total testosterone at 0.6 nanomoles, which she said was within the female reference range reported by the laboratory.
“Under Cricket Australia’s Policy, a player seeking to participate in the female category of Elite Cricket must establish that their serum testosterone concentration has been below 10 nmol/L continuously for a period of no less than 12 months,” CA said in an email to Anaya. Anaya said the process was neither “automatic or informal” and that CA had considered her medical and surgical history, hormone and testosterone levels, cricketing background, playing footage and scientific and athletic performance work conducted with Manchester Metropolitan University’s Institute of Sport. I still have to train, compete, perform and earn that opportunity,” she said. “This is why I respect the process Cricket Australia has followed in considering my case,” she said, adding that one of the most difficult possibilities she had faced after transitioning was that cricket might no longer have a place for her. She said she had spent years trying to find a way back and that CA’s decision had finally given her “a pathway to try”.
An expert panel comprising CA’s Head of Integrity Jacqui Partridge, Integrity Partner and Legal representative Emily Yates, Head of Scheduling, Operations and Domestic Cricket Peter Roach, Anti-Doping Medical Officer Dr Peter Harcourt and Team Doctor Dr Pip Inge considered Anaya’s case before confirming the pathway. “I want to make another point very clearly. Eligibility is not selection. Cricket Australia has given me a pathway, which does not mean that I have been given a place in a team. “I don’t expect my history or my identity to earn me a place on a cricket team. I want my cricket to earn me a place on a cricket team,” she added.